The full dataset viewer is not available (click to read why). Only showing a preview of the rows.
Error code: JobManagerCrashedError
Need help to make the dataset viewer work? Make sure to review how to configure the dataset viewer, and open a discussion for direct support.
path string | id string | title string | content string | contents string | license string |
|---|---|---|---|---|---|
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_0 | Changing Diagnostic Paradigms for Microbiology | Near-patient and point-of-care (POC) testing for infectious disease diagnostics is rapidly evolving. The American Academy of Microbiology convened a colloquium in October 2016 to explore the impact of near-patient and POC tests on patient outcomes, healthcare delivery models, public health, and healthcare costs. This r... | Changing Diagnostic Paradigms for Microbiology. Near-patient and point-of-care (POC) testing for infectious disease diagnostics is rapidly evolving. The American Academy of Microbiology convened a colloquium in October 2016 to explore the impact of near-patient and POC tests on patient outcomes, healthcare delivery mod... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_1 | Changing Diagnostic Paradigms for Microbiology | ensure that the best-quality tests are ordered and interpreted correctly to benefit patient care. The American Academy of Microbiology (Academy) is the honorific branch of the American Society for Microbiology (ASM), a nonprofit scientific society with nearly 48,000 members. Fellows of the Academy have been elected by ... | Changing Diagnostic Paradigms for Microbiology. ensure that the best-quality tests are ordered and interpreted correctly to benefit patient care. The American Academy of Microbiology (Academy) is the honorific branch of the American Society for Microbiology (ASM), a nonprofit scientific society with nearly 48,000 membe... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_2 | Changing Diagnostic Paradigms for Microbiology | that the information is accurate and complete. The contents reflect the views of the participants and are not intended to reflect official positions of the Academy or of ASM. The Academy acknowledges Margaret Milhous for her assistance in editing this report. In addition, the Academy thanks the efforts of Daniel Penist... | Changing Diagnostic Paradigms for Microbiology. that the information is accurate and complete. The contents reflect the views of the participants and are not intended to reflect official positions of the Academy or of ASM. The Academy acknowledges Margaret Milhous for her assistance in editing this report. In addition,... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_3 | Changing Diagnostic Paradigms for Microbiology | for infectious indications. Currently, laboratories face increased pressures to perform more testing while reducing turnaround times in the setting of high staff turnover and staff shortages. Centralized laboratories may need to serve an increasing number of decentralized patients in a system or network affiliated with... | Changing Diagnostic Paradigms for Microbiology. for infectious indications. Currently, laboratories face increased pressures to perform more testing while reducing turnaround times in the setting of high staff turnover and staff shortages. Centralized laboratories may need to serve an increasing number of decentralized... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_4 | Changing Diagnostic Paradigms for Microbiology | on-demand testing) in order to optimize use of resources. In addition, delivery mechanisms are changing in healthcare. Some settings (such as rapid or convenient care clinics or clinics in the developing world) do not have a dedicated microbiology laboratory and require testing methods that require minimal designated s... | Changing Diagnostic Paradigms for Microbiology. on-demand testing) in order to optimize use of resources. In addition, delivery mechanisms are changing in healthcare. Some settings (such as rapid or convenient care clinics or clinics in the developing world) do not have a dedicated microbiology laboratory and require t... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_5 | Changing Diagnostic Paradigms for Microbiology | Near-patient and point-of-care (POC) testing increases access to efficient diagnostic testing across many settings; this field is rapidly advancing. Clinical Laboratory Improvement Amendments (CLIA)-waived nucleic acid amplification tests (NAATs) can be performed outside laboratories by nonlaboratorians while producing... | Changing Diagnostic Paradigms for Microbiology. Near-patient and point-of-care (POC) testing increases access to efficient diagnostic testing across many settings; this field is rapidly advancing. Clinical Laboratory Improvement Amendments (CLIA)-waived nucleic acid amplification tests (NAATs) can be performed outside ... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_6 | Changing Diagnostic Paradigms for Microbiology | Rapid diagnostic tests have the potential to deliver timely results to enable treatment decisions in both laboratory and nonlaboratory settings. Such tests could, for example, detect the presence of biomarkers, distinguish between viral and bacterial infections, identify causative organisms, determine strain type, or p... | Changing Diagnostic Paradigms for Microbiology. Rapid diagnostic tests have the potential to deliver timely results to enable treatment decisions in both laboratory and nonlaboratory settings. Such tests could, for example, detect the presence of biomarkers, distinguish between viral and bacterial infections, identify ... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_7 | Changing Diagnostic Paradigms for Microbiology | decisions as well as the public health response when outbreaks are rapidly identified. Expertise in the microbial sciences is needed to guide the development and utilization of new tests, as are oversight and proficiency testing to ensure that the tests are being conducted correctly and that results are reported to the... | Changing Diagnostic Paradigms for Microbiology. decisions as well as the public health response when outbreaks are rapidly identified. Expertise in the microbial sciences is needed to guide the development and utilization of new tests, as are oversight and proficiency testing to ensure that the tests are being conducte... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_8 | Changing Diagnostic Paradigms for Microbiology | the world's oldest and largest life science organization. One major role of the Academy is to convene colloquia to deliberate on issues of critical importance in the microbial sciences. On 17 to 18 October 2016, the Academy convened a group of 21 experts at ASM Headquarters to discuss changing diagnostic paradigms in m... | Changing Diagnostic Paradigms for Microbiology. the world's oldest and largest life science organization. One major role of the Academy is to convene colloquia to deliberate on issues of critical importance in the microbial sciences. On 17 to 18 October 2016, the Academy convened a group of 21 experts at ASM Headquarte... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_9 | Changing Diagnostic Paradigms for Microbiology | and POC testing, pharmacy, medicine, laboratory medicine, public health, informatics, device development, device regulation, and investment. Colloquium participants were assigned 11 main discussion questions, with subquestions that covered the broad topics in the Statement of Task (see the ). Participants were divided ... | Changing Diagnostic Paradigms for Microbiology. and POC testing, pharmacy, medicine, laboratory medicine, public health, informatics, device development, device regulation, and investment. Colloquium participants were assigned 11 main discussion questions, with subquestions that covered the broad topics in the Statemen... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_10 | Changing Diagnostic Paradigms for Microbiology | have a negative test result. This indicates the ability of the test to correctly identify those patients without the disease. βthe proportion of patients with a positive test result who actually have the disease. The value is dependent on the prevalence of the disease in the patient population. βthe proportion of patie... | Changing Diagnostic Paradigms for Microbiology. have a negative test result. This indicates the ability of the test to correctly identify those patients without the disease. βthe proportion of patients with a positive test result who actually have the disease. The value is dependent on the prevalence of the disease in ... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_11 | Changing Diagnostic Paradigms for Microbiology | tests that are determined to be of moderate or high complexity and need to be performed in a laboratory that is inspected by a regulatory agency. βan imprecise term used to describe laboratory testing (with a waived or nonwaived test) that can be performed in close proximity to the patient, either at the point of care ... | Changing Diagnostic Paradigms for Microbiology. tests that are determined to be of moderate or high complexity and need to be performed in a laboratory that is inspected by a regulatory agency. βan imprecise term used to describe laboratory testing (with a waived or nonwaived test) that can be performed in close proxim... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_12 | Changing Diagnostic Paradigms for Microbiology | the site where the patient is located, that do not require permanent dedicated space, and that are performed outside the physical facilities of the clinical laboratoriesβ. βPOC testing is diagnostic testing that will result in a clear and actionable management decision such as when to start treatment or to require a co... | Changing Diagnostic Paradigms for Microbiology. the site where the patient is located, that do not require permanent dedicated space, and that are performed outside the physical facilities of the clinical laboratoriesβ. βPOC testing is diagnostic testing that will result in a clear and actionable management decision su... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_13 | Changing Diagnostic Paradigms for Microbiology | can refer to tests performed at or close to the site of patient care, by nonlaboratory personnel, with results available more quickly than with tests performed by a central laboratory. Definitions for these terms vary, as indicated by the sample definitions provided in the . Usage of the terms may also depend on the se... | Changing Diagnostic Paradigms for Microbiology. can refer to tests performed at or close to the site of patient care, by nonlaboratory personnel, with results available more quickly than with tests performed by a central laboratory. Definitions for these terms vary, as indicated by the sample definitions provided in th... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_14 | Changing Diagnostic Paradigms for Microbiology | immunochromatographic membrane-based assays) and nucleic acid tests. Due to rapid advances in technology, the field of diagnostic microbiology is shifting from antigen-based testing to nucleic acid amplification-based testing, including multiplex syndromic panels that test for a number of potential pathogens concurrent... | Changing Diagnostic Paradigms for Microbiology. immunochromatographic membrane-based assays) and nucleic acid tests. Due to rapid advances in technology, the field of diagnostic microbiology is shifting from antigen-based testing to nucleic acid amplification-based testing, including multiplex syndromic panels that tes... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_15 | Changing Diagnostic Paradigms for Microbiology | acid amplification tests (NAATs) can detect RNA or DNA sequences specific to a particular target (which may be present in a specific pathogen or antimicrobial resistance determinant). NAATs include PCR (nucleic acid amplification using thermostable polymerase) or isothermal amplification methods, including transcriptio... | Changing Diagnostic Paradigms for Microbiology. acid amplification tests (NAATs) can detect RNA or DNA sequences specific to a particular target (which may be present in a specific pathogen or antimicrobial resistance determinant). NAATs include PCR (nucleic acid amplification using thermostable polymerase) or isotherm... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_16 | Changing Diagnostic Paradigms for Microbiology | practice versus in controlled clinical trials performed for regulatory review or due to genetic differences in circulating strains. NAATs have a risk of contamination during nucleic acid extraction or from carryover of previously amplified material, including vaccines, or from leakage of test cartridges, which may affe... | Changing Diagnostic Paradigms for Microbiology. practice versus in controlled clinical trials performed for regulatory review or due to genetic differences in circulating strains. NAATs have a risk of contamination during nucleic acid extraction or from carryover of previously amplified material, including vaccines, or... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_17 | Changing Diagnostic Paradigms for Microbiology | by a NAAT is costly and requires specialized equipment. Antigen-based rapid influenza diagnostic tests (RIDTs) are a less expensive and faster option for influenza diagnosis. However, many of these tests exhibit poor sensitivity, particularly in postmarket studies in the United States. A meta-analysis of RIDT studies f... | Changing Diagnostic Paradigms for Microbiology. by a NAAT is costly and requires specialized equipment. Antigen-based rapid influenza diagnostic tests (RIDTs) are a less expensive and faster option for influenza diagnosis. However, many of these tests exhibit poor sensitivity, particularly in postmarket studies in the ... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_18 | Changing Diagnostic Paradigms for Microbiology | due to the high specificity and positive predictive value when used during respiratory season, positive antigen-based tests can be used to guide appropriate therapy for influenza (e.g., antiviral medication). NAATs have improved the diagnosis of TB, particularly in developing nations with high prevalences of TB. Tradit... | Changing Diagnostic Paradigms for Microbiology. due to the high specificity and positive predictive value when used during respiratory season, positive antigen-based tests can be used to guide appropriate therapy for influenza (e.g., antiviral medication). NAATs have improved the diagnosis of TB, particularly in develo... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_19 | Changing Diagnostic Paradigms for Microbiology | day as the healthcare visit. POC nucleic acid tests for TB are rapid, sensitive, and specific and have the potential to replace smear microscopy. Nucleic acid tests also have the ability to identify multidrug-resistant TB (resistant to at least isoniazid and rifampin, two of the first-line therapeutic agents). With the... | Changing Diagnostic Paradigms for Microbiology. day as the healthcare visit. POC nucleic acid tests for TB are rapid, sensitive, and specific and have the potential to replace smear microscopy. Nucleic acid tests also have the ability to identify multidrug-resistant TB (resistant to at least isoniazid and rifampin, two... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_20 | Changing Diagnostic Paradigms for Microbiology | meningitis/encephalitis, and for gastrointestinal pathogens. Syndromic panels must be thoughtfully developed to provide advantages over single-pathogen tests; the clinical utility of including each pathogen should be considered to ensure that the test results are easily interpretable. Differences in sensitivity and spe... | Changing Diagnostic Paradigms for Microbiology. meningitis/encephalitis, and for gastrointestinal pathogens. Syndromic panels must be thoughtfully developed to provide advantages over single-pathogen tests; the clinical utility of including each pathogen should be considered to ensure that the test results are easily i... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_21 | Changing Diagnostic Paradigms for Microbiology | to testing is needed. Professional judgment may be required to determine when a panel approach is warranted and to interpret the results of a syndromic panel correctly. For example, a patientβs clinical presentation might be the result of a newly recognized pathogen (in which case, it would not be identified with a pan... | Changing Diagnostic Paradigms for Microbiology. to testing is needed. Professional judgment may be required to determine when a panel approach is warranted and to interpret the results of a syndromic panel correctly. For example, a patientβs clinical presentation might be the result of a newly recognized pathogen (in w... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_22 | Changing Diagnostic Paradigms for Microbiology | positive results are clinically significant and which might be insignificant. Pharyngitis (sore throat), which results in an estimated 15 million medical visits annually in the United States, can be caused by viral or bacterial pathogens. A nucleic acid syndromic panel could cover key infectious causes of pharyngitis t... | Changing Diagnostic Paradigms for Microbiology. positive results are clinically significant and which might be insignificant. Pharyngitis (sore throat), which results in an estimated 15 million medical visits annually in the United States, can be caused by viral or bacterial pathogens. A nucleic acid syndromic panel co... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_23 | Changing Diagnostic Paradigms for Microbiology | is important to inform treatment. Testing for multiple targets simultaneously could allow providers to more rapidly determine causes of pharyngitis and either initiate antibiotic treatment for GAS or to inform the patient that his/her sore throat is caused by an agent for which antibiotics are not warranted. A syndromi... | Changing Diagnostic Paradigms for Microbiology. is important to inform treatment. Testing for multiple targets simultaneously could allow providers to more rapidly determine causes of pharyngitis and either initiate antibiotic treatment for GAS or to inform the patient that his/her sore throat is caused by an agent for... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_24 | Changing Diagnostic Paradigms for Microbiology | performance criteria for sensitivity and specificity similar to those of equivalent laboratory-based tests. Even with the best quality tests (whether performed in the laboratory or at the POC), providers need to be wary of adverse outcomes that can arise from improper interpretation of the results. Concerns exist that ... | Changing Diagnostic Paradigms for Microbiology. performance criteria for sensitivity and specificity similar to those of equivalent laboratory-based tests. Even with the best quality tests (whether performed in the laboratory or at the POC), providers need to be wary of adverse outcomes that can arise from improper int... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_25 | Changing Diagnostic Paradigms for Microbiology | infection. In addition, the pretest probabilities of a particular result and therefore of the positive predictive value of the test in that particular setting for that particular patient population need to be considered. Recommendations to guide oversight of near-patient and POC testing, such as addressing contaminatio... | Changing Diagnostic Paradigms for Microbiology. infection. In addition, the pretest probabilities of a particular result and therefore of the positive predictive value of the test in that particular setting for that particular patient population need to be considered. Recommendations to guide oversight of near-patient ... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_26 | Changing Diagnostic Paradigms for Microbiology | disease. Given these considerations, it would be advantageous to develop a rapid and simple test that reliably detects a broader range of spp.. In the United States, most diagnostic tests are regulated by the Food and Drug Administration (FDA) (see the ). CLIA regulates laboratory testing and requires clinical laborato... | Changing Diagnostic Paradigms for Microbiology. disease. Given these considerations, it would be advantageous to develop a rapid and simple test that reliably detects a broader range of spp.. In the United States, most diagnostic tests are regulated by the Food and Drug Administration (FDA) (see the ). CLIA regulates l... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_27 | Changing Diagnostic Paradigms for Microbiology | CLIA waiver may be granted for a test after the clearance or approval process or through a dual pathway in which the clearance and waiver occur simultaneously [known as a Dual 510(k) and CLIA Waiver Application]. Settings that perform only certain tests that are simple to use and have an insignificant risk of an errone... | Changing Diagnostic Paradigms for Microbiology. CLIA waiver may be granted for a test after the clearance or approval process or through a dual pathway in which the clearance and waiver occur simultaneously [known as a Dual 510(k) and CLIA Waiver Application]. Settings that perform only certain tests that are simple to... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_28 | Changing Diagnostic Paradigms for Microbiology | involves a more rigorous premarket review than the 510(k) pathway.β βCleared medical devices: These medical devices are ones that FDA has determined to be substantially equivalent to another legally marketed device. A premarket notification, referred to as a 510(k), must be submitted to FDA for clearance. A 510(k) is m... | Changing Diagnostic Paradigms for Microbiology. involves a more rigorous premarket review than the 510(k) pathway.β βCleared medical devices: These medical devices are ones that FDA has determined to be substantially equivalent to another legally marketed device. A premarket notification, referred to as a 510(k), must ... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_29 | Changing Diagnostic Paradigms for Microbiology | syncytial virus, and GAS and a syndromic respiratory panel that tests for,coronaviruses, influenza A H1 virus, influenza A H3 virus, influenza A H1-2009 virus, influenza B virus,parainfluenza viruses, and from a single patient sample. Outside the United States, other regulatory paradigms exist. For example, for the Eur... | Changing Diagnostic Paradigms for Microbiology. syncytial virus, and GAS and a syndromic respiratory panel that tests for,coronaviruses, influenza A H1 virus, influenza A H3 virus, influenza A H1-2009 virus, influenza B virus,parainfluenza viruses, and from a single patient sample. Outside the United States, other regu... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_30 | Changing Diagnostic Paradigms for Microbiology | advancing. Future tests may be able to deliver results with a faster turnaround time than currently available. Ideally, tests would be read by an instrument and electronically interfaced to reduce interpretation errors and to ensure that data are shared. Advances in technology can change the current paradigm in which h... | Changing Diagnostic Paradigms for Microbiology. advancing. Future tests may be able to deliver results with a faster turnaround time than currently available. Ideally, tests would be read by an instrument and electronically interfaced to reduce interpretation errors and to ensure that data are shared. Advances in techn... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_31 | Changing Diagnostic Paradigms for Microbiology | targets include sexually transmitted infections (STIs), pharyngitis, urinary tract infections (particularly tests that distinguish between infection and noninfection), and community-acquired pneumonia (particularly tests that distinguish between viral and bacterial pneumonia). For STIs and pharyngitis, nucleic acid tes... | Changing Diagnostic Paradigms for Microbiology. targets include sexually transmitted infections (STIs), pharyngitis, urinary tract infections (particularly tests that distinguish between infection and noninfection), and community-acquired pneumonia (particularly tests that distinguish between viral and bacterial pneumo... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_32 | Changing Diagnostic Paradigms for Microbiology | Future tests may also be able to provide more detailed information than is currently available through POC tests, such as antimicrobial resistance or the ability to quantitate organisms. New tests may be able to identify host biomarkers of infection to guide treatment (even when a test for the etiologic agent is not av... | Changing Diagnostic Paradigms for Microbiology. Future tests may also be able to provide more detailed information than is currently available through POC tests, such as antimicrobial resistance or the ability to quantitate organisms. New tests may be able to identify host biomarkers of infection to guide treatment (ev... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_33 | Changing Diagnostic Paradigms for Microbiology | microbiome to monitor health and predict disease risk, leading to βpersonalized microbial medicine.β Due to their expertise and experience with diagnostic tests for infectious agents, clinical microbiology laboratory personnel can complete clinical needs assessments to guide future directions for test development. For ... | Changing Diagnostic Paradigms for Microbiology. microbiome to monitor health and predict disease risk, leading to βpersonalized microbial medicine.β Due to their expertise and experience with diagnostic tests for infectious agents, clinical microbiology laboratory personnel can complete clinical needs assessments to gu... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_34 | Changing Diagnostic Paradigms for Microbiology | new technologies. Regardless of the technology, it is vital to ensure that POC tests will perform accurately and reproducibly when used according to the manufacturerβs instructions. Removing the test from the laboratory removes the ability for analysis and βtroubleshootingβ by experienced personnel. Given the potential... | Changing Diagnostic Paradigms for Microbiology. new technologies. Regardless of the technology, it is vital to ensure that POC tests will perform accurately and reproducibly when used according to the manufacturerβs instructions. Removing the test from the laboratory removes the ability for analysis and βtroubleshootin... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_35 | Changing Diagnostic Paradigms for Microbiology | be used by nonlaboratorians must be identified. For example, colloquium participants suggested that contamination should be auto-monitored for NAATs. One way this might be accomplished is if the software accompanying the test device alerts the user when a positive threshold (as established by the user) is exceeded with... | Changing Diagnostic Paradigms for Microbiology. be used by nonlaboratorians must be identified. For example, colloquium participants suggested that contamination should be auto-monitored for NAATs. One way this might be accomplished is if the software accompanying the test device alerts the user when a positive thresho... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_36 | Changing Diagnostic Paradigms for Microbiology | testing as is available in developed countries. A recent Perspective in the called for a model list of essential diagnostics, similar to the Model List of Essential Medicines maintained by the WHO, which could include POC tests. The information gleaned from rapid diagnostics has the potential to inform individual treat... | Changing Diagnostic Paradigms for Microbiology. testing as is available in developed countries. A recent Perspective in the called for a model list of essential diagnostics, similar to the Model List of Essential Medicines maintained by the WHO, which could include POC tests. The information gleaned from rapid diagnost... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_37 | Changing Diagnostic Paradigms for Microbiology | laboratories (such as small physician practices or long-term care facilities) or are outside traditional medical settings (such as convenient care clinics or pharmacies or even at home in conjunction with the practice of telemedicine). Incorporating near-patient and POC testing for infectious disease indications may in... | Changing Diagnostic Paradigms for Microbiology. laboratories (such as small physician practices or long-term care facilities) or are outside traditional medical settings (such as convenient care clinics or pharmacies or even at home in conjunction with the practice of telemedicine). Incorporating near-patient and POC t... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_38 | Changing Diagnostic Paradigms for Microbiology | needs to allow for the test to be performed and for results to be reported in a short turnaround time. This is especially true in convenient care or retail clinics, which provide services for simple acute conditions (the most common reasons for visits include upper respiratory tract infections, sinusitis, and bronchiti... | Changing Diagnostic Paradigms for Microbiology. needs to allow for the test to be performed and for results to be reported in a short turnaround time. This is especially true in convenient care or retail clinics, which provide services for simple acute conditions (the most common reasons for visits include upper respir... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_39 | Changing Diagnostic Paradigms for Microbiology | specimen collection may provide a way to integrate POC tests into a brief clinical encounter at a physicianβs office or convenient care clinic. The workflow could begin with specimen collection ordered through a triage mechanism based on patient symptoms and accomplished through nurse-initiated provider orders. A poten... | Changing Diagnostic Paradigms for Microbiology. specimen collection may provide a way to integrate POC tests into a brief clinical encounter at a physicianβs office or convenient care clinic. The workflow could begin with specimen collection ordered through a triage mechanism based on patient symptoms and accomplished ... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_40 | Changing Diagnostic Paradigms for Microbiology | to be available before the healthcare provider sees the patient. The decreased time to reliable results granted by the utilization of rapid NAATs can enable optimal therapeutic management to occur more quickly and can foster better adherence to clinical treatment guidelines. One particular area in which near-patient an... | Changing Diagnostic Paradigms for Microbiology. to be available before the healthcare provider sees the patient. The decreased time to reliable results granted by the utilization of rapid NAATs can enable optimal therapeutic management to occur more quickly and can foster better adherence to clinical treatment guidelin... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_41 | Changing Diagnostic Paradigms for Microbiology | they do want an answer. The results of rapid diagnostic tests could provide a basis for the provider to explain the recommended therapy (or lack thereof) to the patient. Near-patient and POC tests contributing to antimicrobial stewardship might also support requirements under Joint Commission accreditation or CMS Condi... | Changing Diagnostic Paradigms for Microbiology. they do want an answer. The results of rapid diagnostic tests could provide a basis for the provider to explain the recommended therapy (or lack thereof) to the patient. Near-patient and POC tests contributing to antimicrobial stewardship might also support requirements u... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_42 | Changing Diagnostic Paradigms for Microbiology | may be able to test only a limited number of samples concurrently, so scaling up test volume might be problematic for a high-volume setting. In some situations in the developing world, such as for multidrug-resistant TB, appropriate treatment may not be available even if test results are known, which provides little in... | Changing Diagnostic Paradigms for Microbiology. may be able to test only a limited number of samples concurrently, so scaling up test volume might be problematic for a high-volume setting. In some situations in the developing world, such as for multidrug-resistant TB, appropriate treatment may not be available even if ... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_43 | Changing Diagnostic Paradigms for Microbiology | seen rather than to require a follow-up visit. In regions where infectious disease testing is currently unavailable, especially in developing countries, POC tests can provide critical information to inform both diagnosis and treatment. With expansion of near-patient and POC testing, driven by provider uptake and/or pat... | Changing Diagnostic Paradigms for Microbiology. seen rather than to require a follow-up visit. In regions where infectious disease testing is currently unavailable, especially in developing countries, POC tests can provide critical information to inform both diagnosis and treatment. With expansion of near-patient and P... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_44 | Changing Diagnostic Paradigms for Microbiology | an art,β and POC test results are only one piece of information out of many in the clinical picture that providers should consider when assessing a particular patient. It is vital that the results of POC tests are entered into the laboratory results section of the electronic medical record (EMR) of the patient, so that... | Changing Diagnostic Paradigms for Microbiology. an art,β and POC test results are only one piece of information out of many in the clinical picture that providers should consider when assessing a particular patient. It is vital that the results of POC tests are entered into the laboratory results section of the electro... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_45 | Changing Diagnostic Paradigms for Microbiology | which can lead to adverse outcomes, either in terms of progression of illness in the patient or continued spread of the untreated disease. False positives, due to contamination, colonization, or incorrect interpretation, may result in inappropriate treatment. If near-patient and POC tests are utilized wisely as part of... | Changing Diagnostic Paradigms for Microbiology. which can lead to adverse outcomes, either in terms of progression of illness in the patient or continued spread of the untreated disease. False positives, due to contamination, colonization, or incorrect interpretation, may result in inappropriate treatment. If near-pati... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_46 | Changing Diagnostic Paradigms for Microbiology | for testing could even be collected at home and sent for testing to a reference laboratory, obviating the need to visit the physicianβs office or emergency department altogether, if results can be returned rapidly. POC test results may also reduce the spread of disease by optimizing antimicrobial therapy earlier in the... | Changing Diagnostic Paradigms for Microbiology. for testing could even be collected at home and sent for testing to a reference laboratory, obviating the need to visit the physicianβs office or emergency department altogether, if results can be returned rapidly. POC test results may also reduce the spread of disease by... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_47 | Changing Diagnostic Paradigms for Microbiology | such as earlier treatment initiation, reduced loss to follow-up, and improved linkage to care and treatment. A review of POC tests for STIs reports findings from a mathematical model that molecular POC tests with high sensitivity can reduce the prevalence of chlamydia and gonorrhea in high-prevalence settings; even POC... | Changing Diagnostic Paradigms for Microbiology. such as earlier treatment initiation, reduced loss to follow-up, and improved linkage to care and treatment. A review of POC tests for STIs reports findings from a mathematical model that molecular POC tests with high sensitivity can reduce the prevalence of chlamydia and... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_48 | Changing Diagnostic Paradigms for Microbiology | workflows as a result of increased POC testing may result in healthcare providers spending more time with their patients and addressing their questions, thus increasing satisfaction scores. POC tests will enable much more in-home testing for infectious diseases in the future. In-home tests may lead to increased patient... | Changing Diagnostic Paradigms for Microbiology. workflows as a result of increased POC testing may result in healthcare providers spending more time with their patients and addressing their questions, thus increasing satisfaction scores. POC tests will enable much more in-home testing for infectious diseases in the fut... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_49 | Changing Diagnostic Paradigms for Microbiology | samples allow the patient to mail their specimen to a laboratory for testing. Additional kits for GAS, gonorrhea, chlamydia, and influenza will likely be available soon. Patients could collect their own samples at home and either bring the specimen into a laboratory or run the test at home. The use of in-home tests wil... | Changing Diagnostic Paradigms for Microbiology. samples allow the patient to mail their specimen to a laboratory for testing. Additional kits for GAS, gonorrhea, chlamydia, and influenza will likely be available soon. Patients could collect their own samples at home and either bring the specimen into a laboratory or ru... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_50 | Changing Diagnostic Paradigms for Microbiology | technology. Additionally, specific in-home collection kits could be developed with specialized equipment to make sample collection easier for the public. Public health surveillance is important for monitoring the epidemiology of infectious diseases, identifying outbreaks or epidemics, and informing strategies to addres... | Changing Diagnostic Paradigms for Microbiology. technology. Additionally, specific in-home collection kits could be developed with specialized equipment to make sample collection easier for the public. Public health surveillance is important for monitoring the epidemiology of infectious diseases, identifying outbreaks ... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_51 | Changing Diagnostic Paradigms for Microbiology | may be needed for public health agencies to link cases to an outbreak. Public health agencies have traditionally needed isolates in pure culture for pathogen characterization and analysis, but near-patient and POC tests are culture independent. Some near-patient and POC collection devices inactivate any pathogens prese... | Changing Diagnostic Paradigms for Microbiology. may be needed for public health agencies to link cases to an outbreak. Public health agencies have traditionally needed isolates in pure culture for pathogen characterization and analysis, but near-patient and POC tests are culture independent. Some near-patient and POC c... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_52 | Changing Diagnostic Paradigms for Microbiology | of increased near-patient and POC culture-independent testing, test users, clinical microbiology laboratories, and public health agencies need to develop methods to allow for continued public health surveillance. With an increase in culture-independent testing and decentralized data sets, it might be more difficult to ... | Changing Diagnostic Paradigms for Microbiology. of increased near-patient and POC culture-independent testing, test users, clinical microbiology laboratories, and public health agencies need to develop methods to allow for continued public health surveillance. With an increase in culture-independent testing and decentr... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_53 | Changing Diagnostic Paradigms for Microbiology | health response. When relevant surveillance information is shared with public health authorities, it is important that patient confidentiality be maintained. With near-patient and POC tests being performed in an increasing number of settings and with the possibility for increased numbers of home-based testing platforms... | Changing Diagnostic Paradigms for Microbiology. health response. When relevant surveillance information is shared with public health authorities, it is important that patient confidentiality be maintained. With near-patient and POC tests being performed in an increasing number of settings and with the possibility for i... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_54 | Changing Diagnostic Paradigms for Microbiology | reports. Rather than each healthcare system or provider individually holding a patientβs data and granting access of the data to the patient, in the future, patients may have a singular EMR database or a personal health record that contains all of their EMR data, and patients might grant access of the data to their pro... | Changing Diagnostic Paradigms for Microbiology. reports. Rather than each healthcare system or provider individually holding a patientβs data and granting access of the data to the patient, in the future, patients may have a singular EMR database or a personal health record that contains all of their EMR data, and pati... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_55 | Changing Diagnostic Paradigms for Microbiology | and upload to their EMR. Informatics support and IT security measures are needed to encrypt data and ensure data protection and confidentiality. While connectivity and sharing of test results are not currently routine practice in all settings, test manufacturers should include clear wording on the test package regardin... | Changing Diagnostic Paradigms for Microbiology. and upload to their EMR. Informatics support and IT security measures are needed to encrypt data and ensure data protection and confidentiality. While connectivity and sharing of test results are not currently routine practice in all settings, test manufacturers should in... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_56 | Changing Diagnostic Paradigms for Microbiology | laboratories traditionally ensure that diagnostic testing is accurate and safe. With the changing paradigms for infectious disease diagnostics, personnel without specific laboratory medicine training, who may not be accustomed or required to perform proficiency testing or quality assurance, will perform testing. There ... | Changing Diagnostic Paradigms for Microbiology. laboratories traditionally ensure that diagnostic testing is accurate and safe. With the changing paradigms for infectious disease diagnostics, personnel without specific laboratory medicine training, who may not be accustomed or required to perform proficiency testing or... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
./d1/23/aamcol1718oct2016_NBK447255 | aamcol1718oct2016_NBK447255_57 | Changing Diagnostic Paradigms for Microbiology | when clinical microbiology expertise is available in a healthcare setting, the laboratory should retain oversight of the quality assurance of infectious disease diagnostic tests, even those that are performed outside the laboratory. However, lack of staffing is currently a challenge for clinical microbiology laboratori... | Changing Diagnostic Paradigms for Microbiology. when clinical microbiology expertise is available in a healthcare setting, the laboratory should retain oversight of the quality assurance of infectious disease diagnostic tests, even those that are performed outside the laboratory. However, lack of staffing is currently ... | Terms of Use for d1/23/aamcol1718oct2016_NBK447255.tar.gz; Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016; American Society for Microbiology; 2017; NBK447255 For each document, read the license and copyright sta... |
YAML Metadata Warning:empty or missing yaml metadata in repo card
Check out the documentation for more information.
Special Notice
For this dataset, we leveraged $8,226$ open-access medical textbooks from the NLM LitArch Open Access Subset, hosted by the U.S. National Library of Medicine.
Agentic Medical RAG
Agentic Memory-augmented Retrieval and Evidence Grounding in Medicine
π Announcements
[2026.06.01]
Our Agentic Medical RAG manuscript is published in International Journal of Medical Informatics. Link to the paper and Supplementary Material.
π Table of contents
- Agentic medical RAG
- Installation
- Quick start
- Prompt format
- Toolkit description
- Dataset description
- Benchmarks and results
- Real-world deployment
- Algorithm
- Structure of the code
- Citation
- Contact
- Contributions
- Acknowledgements
Agentic medical RAG
We developed a unified, open-source LLM-based agentic system that integrates document retrieval, re-ranking, evidence grounding, and diagnosis generation to support dynamic, multi-step medical reasoning.
Our system features a lightweight retrieval-augmented generation pipeline coupled with a cache-and-prune memory bank, enabling efficient long-context inference beyond standard LLM limits.
The system autonomously invokes specialized tools, eliminating the need for manual prompt engineering or brittle multi-stage templates.
π» Installation
At the time, this work was conducted using 4 NVIDIA L40S GPUs. To facilitate package installation and dependency configuration, we validated our agentic system on 2 NVIDIA RTX PRO 6000 Blackwell GPUs running CUDA 13.2 and 0.17.0+cu132.
Please NOTE that our vLLM installation is built from source instead of direct pip install.
First, create a Python 3.10 environment (higher versions should work as well), then
pip install -r requirements.txt
Then, the most important part is to install/compile vLLM:
- Manually download the vLLM 0.17.0 source code from https://github.com/vllm-project/vllm/releases/tag/v0.17.0.
tar -xvzf vllm-0.17.0.tar.gzpip install --editable vllm-0.17.0 --no-cache-dir
Then, the vLLM will be compiled from source and installed. Other vLLM versions (e.g., 0.6.3), can also be compiled in this way.
To set up the Transformers and Triton saving path, run the following commands in your terminal:
For example, if your path is /projectnb/vkolagrp/:
export TRANSFORMERS_CACHE=/projectnb/vkolagrp/.cache
export HF_HOME=/projectnb/vkolagrp/.cache
export HF_DATASETS_CACHE=/projectnb/vkolagrp/.cache
export TRITON_CACHE_DIR=/projectnb/vkolagrp/.cache/.triton
Please change /projectnb/vkolagrp/ to your own path. After running the commands, all your Transformers models and datasets will be saved in the paths you defined.
π Quick start
We use a two-stage retrieval pipeline:
- Document retrieval: SPECTER performs coarse-grained semantic search over each evidence source and retrieves the top-K candidate documents.
- Evidence reranking: gte-Qwen2-7B-instruct computes fine-grained queryβdocument similarity and selects the top-R most relevant documents for downstream evidence grounding and medical reasoning.
By default, the system retrieves $32$ candidates from each of the six sources, producing $192$ candidates in total, and reranks them to retain the $32$ most relevant documents. This multi-source design provides complementary evidence from biomedical literature, clinical studies, textbooks, case reports, and general medical knowledge.
Retrieval
The retrieval module identifies clinically relevant evidence from six medical and scientific sources:
- PubMed abstracts
- PubMed Central full-text articles
- Medical textbooks
- ClinicalTrials.gov records
- Wikipedia articles
- New England Journal of Medicine (NEJM) clinical case reports
Due to copyright restrictions, the NEJM clinical case report dataset is not included in this open-source release.
To retrieve documents for all supported benchmarks, run:
sh run_retrieve.sh
To retrieve documents for a specific benchmark, run the corresponding command:
python retrieve.py --benchmark USMLE_STEP_1 --save_folder "RETRIEVED_USMLE_STEP_1"
python retrieve.py --benchmark USMLE_STEP_2 --save_folder "RETRIEVED_USMLE_STEP_2"
python retrieve.py --benchmark USMLE_STEP_3 --save_folder "RETRIEVED_USMLE_STEP_3"
python retrieve.py --benchmark MedQA --save_folder "RETRIEVED_MedQA"
python retrieve.py --benchmark MedExpQA --save_folder "RETRIEVED_MedExpQA"
python retrieve.py --benchmark PubMedQA --save_folder "RETRIEVED_PubMedQA"
Reranking
To rerank the retrieved documents for all supported benchmarks, run:
sh run_rerank.sh
To rerank documents for a specific benchmark, run the corresponding command:
python rerank.py --benchmark USMLE_STEP_1 --doc_folder "RETRIEVED_USMLE_STEP_1" --save_folder "RERANKED_USMLE_STEP_1"
python rerank.py --benchmark USMLE_STEP_2 --doc_folder "RETRIEVED_USMLE_STEP_2" --save_folder "RERANKED_USMLE_STEP_2"
python rerank.py --benchmark USMLE_STEP_3 --doc_folder "RETRIEVED_USMLE_STEP_3" --save_folder "RERANKED_USMLE_STEP_3"
python rerank.py --benchmark MedQA --doc_folder "RETRIEVED_MedQA" --save_folder "RERANKED_MedQA"
python rerank.py --benchmark MedExpQA --doc_folder "RETRIEVED_MedExpQA" --save_folder "RERANKED_MedExpQA"
python rerank.py --benchmark PubMedQA --doc_folder "RETRIEVED_PubMedQA" --save_folder "RERANKED_PubMedQA"
Generation
sh run_diagnosis.sh
or
# USMLE STEP 3 Benchmark
python diagnosis.py --benchmark USMLE_STEP_3 --mode "tool_using_open_book" --doc_folder "RERANKED_USMLE_STEP_3" --save_folder "RESULTS_USMLE_STEP_3"
python diagnosis.py --benchmark USMLE_STEP_3 --mode "tool_using_close_book" --doc_folder "RERANKED_USMLE_STEP_3" --save_folder "RESULTS_USMLE_STEP_3"
python diagnosis.py --benchmark USMLE_STEP_3 --mode "direct_prompt" --doc_folder "RERANKED_USMLE_STEP_3" --save_folder "RESULTS_USMLE_STEP_3"
python diagnosis.py --benchmark USMLE_STEP_3 --mode "direct_prompt_with_evidence" --doc_folder "RERANKED_USMLE_STEP_3" --save_folder "RESULTS_USMLE_STEP_3"
python diagnosis.py --benchmark USMLE_STEP_3 --mode "unstructured_prompt_with_evidence" --doc_folder "RERANKED_USMLE_STEP_3" --save_folder "RESULTS_USMLE_STEP_3"
# USMLE STEP 2 Benchmark
python diagnosis.py --benchmark USMLE_STEP_2 --mode "tool_using_open_book" --doc_folder "RERANKED_USMLE_STEP_2" --save_folder "RESULTS_USMLE_STEP_2"
python diagnosis.py --benchmark USMLE_STEP_2 --mode "tool_using_close_book" --doc_folder "RERANKED_USMLE_STEP_2" --save_folder "RESULTS_USMLE_STEP_2"
python diagnosis.py --benchmark USMLE_STEP_2 --mode "direct_prompt" --doc_folder "RERANKED_USMLE_STEP_2" --save_folder "RESULTS_USMLE_STEP_2"
python diagnosis.py --benchmark USMLE_STEP_2 --mode "direct_prompt_with_evidence" --doc_folder "RERANKED_USMLE_STEP_2" --save_folder "RESULTS_USMLE_STEP_2"
python diagnosis.py --benchmark USMLE_STEP_2 --mode "unstructured_prompt_with_evidence" --doc_folder "RERANKED_USMLE_STEP_2" --save_folder "RESULTS_USMLE_STEP_2"
# USMLE STEP 1 Benchmark
python diagnosis.py --benchmark USMLE_STEP_1 --mode "tool_using_open_book" --doc_folder "RERANKED_USMLE_STEP_1" --save_folder "RESULTS_USMLE_STEP_1"
python diagnosis.py --benchmark USMLE_STEP_1 --mode "tool_using_close_book" --doc_folder "RERANKED_USMLE_STEP_1" --save_folder "RESULTS_USMLE_STEP_1"
python diagnosis.py --benchmark USMLE_STEP_1 --mode "direct_prompt" --doc_folder "RERANKED_USMLE_STEP_1" --save_folder "RESULTS_USMLE_STEP_1"
python diagnosis.py --benchmark USMLE_STEP_1 --mode "direct_prompt_with_evidence" --doc_folder "RERANKED_USMLE_STEP_1" --save_folder "RESULTS_USMLE_STEP_1"
python diagnosis.py --benchmark USMLE_STEP_1 --mode "unstructured_prompt_with_evidence" --doc_folder "RERANKED_USMLE_STEP_1" --save_folder "RESULTS_USMLE_STEP_1"
# PubMedQA Benchmark
python diagnosis.py --benchmark PubMedQA --mode "tool_using_open_book" --doc_folder "RERANKED_PubMedQA" --save_folder "RESULTS_PubMedQA"
python diagnosis.py --benchmark PubMedQA --mode "tool_using_close_book" --doc_folder "RERANKED_PubMedQA" --save_folder "RESULTS_PubMedQA"
python diagnosis.py --benchmark PubMedQA --mode "direct_prompt" --doc_folder "RERANKED_PubMedQA" --save_folder "RESULTS_PubMedQA"
python diagnosis.py --benchmark PubMedQA --mode "direct_prompt_with_evidence" --doc_folder "RERANKED_PubMedQA" --save_folder "RESULTS_PubMedQA"
python diagnosis.py --benchmark PubMedQA --mode "unstructured_prompt_with_evidence" --doc_folder "RERANKED_PubMedQA" --save_folder "RESULTS_PubMedQA"
# MedExpQA Benchmark
python diagnosis.py --benchmark MedExpQA --mode "tool_using_open_book" --doc_folder "RERANKED_MedExpQA" --save_folder "RESULTS_MedExpQA"
python diagnosis.py --benchmark MedExpQA --mode "tool_using_close_book" --doc_folder "RERANKED_MedExpQA" --save_folder "RESULTS_MedExpQA"
python diagnosis.py --benchmark MedExpQA --mode "direct_prompt" --doc_folder "RERANKED_MedExpQA" --save_folder "RESULTS_MedExpQA"
python diagnosis.py --benchmark MedExpQA --mode "direct_prompt_with_evidence" --doc_folder "RERANKED_MedExpQA" --save_folder "RESULTS_MedExpQA"
python diagnosis.py --benchmark MedExpQA --mode "unstructured_prompt_with_evidence" --doc_folder "RERANKED_MedExpQA" --save_folder "RESULTS_MedExpQA"
# MedQA Benchmark
python diagnosis.py --benchmark MedQA --mode "tool_using_open_book" --doc_folder "RERANKED_MedQA" --save_folder "RESULTS_MedQA"
python diagnosis.py --benchmark MedQA --mode "tool_using_close_book" --doc_folder "RERANKED_MedQA" --save_folder "RESULTS_MedQA"
python diagnosis.py --benchmark MedQA --mode "direct_prompt" --doc_folder "RERANKED_MedQA" --save_folder "RESULTS_MedQA"
python diagnosis.py --benchmark MedQA --mode "direct_prompt_with_evidence" --doc_folder "RERANKED_MedQA" --save_folder "RESULTS_MedQA"
python diagnosis.py --benchmark MedQA --mode "unstructured_prompt_with_evidence" --doc_folder "RERANKED_MedQA" --save_folder "RESULTS_MedQA"
π Prompt format
System prompt
system_prompt = (
"You are a medical professional specializing in evidence-based medicine (EBM). "
"Your role is to answer questions using a systematic approach, integrating the best available "
"research evidence, clinical expertise, and patient-specific factors."
)
User prompt for multiple-choice QA
tool_evidence_prompt = """Here is the background information and question about the patient:
<background>
{background}
</background>
The available answer options are:
<option>
{option}
</option>
Follow these steps to answer the question:
1. Compare each option with the case details, analyzing key clues in the text to identify the best choice.
2. If the question can be answered through comparison, directly return the best option term with the option capital within <final_result></final_result> tags, placing the explanation outside of the <final_result> tags.
3. If multiple options are plausible or additional evidence is needed for better decision-making, enable search to find credible sources.
4. Analyze the relevance between each document and the patient's presentation, followed by a systematic search to locate relevant evidence applicable to the patientβs case.
5. While we are continuing to provide additional evidence, iterate the previous step to analyze more additional evidence.
6. Once sufficient information is gathered, return the best option term with the option capital within <final_result></final_result> tags, placing the explanation outside of the <final_result> tags."""
User prompt for open-ended QA
tool_evidence_prompt = """Here is the background information and question about the patient:
<background>
{background}
</background>
Follow these steps to answer the question:
1. Compare each option with the case details, analyzing key clues in the text to identify the best choice.
2. If the question can be answered through comparison, directly return the best option term with the option capital within <final_result></final_result> tags, placing the explanation outside of the <final_result> tags.
3. If multiple options are plausible or additional evidence is needed for better decision-making, enable search to find credible sources.
4. Analyze the relevance between each document and the patient's presentation, followed by a systematic search to locate relevant evidence applicable to the patientβs case.
5. While we are continuing to provide additional evidence, iterate the previous step to analyze more additional evidence.
6. Once sufficient information is gathered, return the best option term with the option capital within <final_result></final_result> tags, placing the explanation outside of the <final_result> tags."""
User prompt for cache-and-prune memory bank mechanism
document_revise_template = """Here are the selected relevant documents related to the patient's care:
<document>
{document}
</document>
Review your answer and return the best option term with the option capital within the <final_result></final_result> tags, leave the explanation outside of the <final_result> tags."""
π§° Toolkit description
we designed five specialized tools to serve as the diagnostic aid kit within our AI agent. For question interpretation, the agent uses perform_comparison to handle multiple choice tasks and generate_options for open-ended scenarios, enabling flexible reasoning formats. In particular, generate_options is tailored for scenarios lacking predefined choices, enabling the agent to propose plausible answer candidates from the contextual details of the case. Additionally, the enable_search tool determines whether external evidence is necessary to support a diagnosis. To facilitate evidence retrieval and interpretation, relevance_analysis evaluates the semantic alignment between the patientβs case and retrieved documents, while locate_evidence identifies and grounds specific articles most pertinent to the diagnosis.
π Dataset description
The corpus includes research articles published under Creative Commons licenses from leading biomedical journals indexed in PubMed Central. We also incorporated clinical trial records from ClinicalTrials.gov, filtering for studies that had completed recruitment and were classified as Phase 3 or Phase 4, or that investigated device-based or behavioral interventions. This selection yielded $156,887$ trials as of March 2025. To enhance real-world clinical applicability, we included $1,479$ clinical case reports published by the New England Journal of Medicine (NEJM) between 2016 and March2025. We further adopted pre-indexed corpora of PubMed abstracts and Wikipedia entries from Xiong et al., which have demonstrated strong utility for medical question answering (QA) tasks. Finally, we leveraged $8,226$ open-access medical textbooks from the NLM LitArch Open Access Subset, hosted by the U.S. National Library of Medicine.
π Benchmarks and results
Benchmark datasets
We evaluated our system using five medical question answering benchmarks: the United States medical
licensing examination (USMLE) Steps 1-3, free-form multiple-choice open-domain medical QA (MedQA), and
medical explanation-based QA (MedExpQA) (Table 3). Each benchmark includes clinical case descriptions,
multiple-choice options, and a correct answer.
Multiple-choice QA performance
We manually evaluated the accuracy of all models, including BioMistral (7B), OpenBioLLM (8B and 70B), UltraMedical (8B and 70B), and PodGPT (70B).
Open-ended QA performance
We manually evaluated the performance of all models, including BioMistral (7B), OpenBioLLM (8B and 70B), UltraMedical (8B and 70B), and PodGPT (70B), using three embedding-based metrics: BERTScore F1 computed with deberta-xlarge-mnli, similarity scores from SFR-Embedding-2_R, and similarity scores from gte-Qwen2-7B-instruct models.
We provide evaluation code here.
Tool-usage analysis
We analyzed the agent's tool usage patterns, and provide our code (Figure 2(a)) and code (Figure 2(b)) to generate these figures.
Ablation study
We compared performance with and without tool access to evaluate the impact of incorporating tools into the agentic pipeline.
π₯ Real-world deployment
For real-world deployment, please refer to the vLLM Distributed Inference and Serving and OpenAI Compatible Server. We provide a deployment script here.
At the time, the vLLM version we were using was
0.6.3to serve the Qwen2.5 72B model. Please check this version.
vLLM can be deployed as a server that implements the OpenAI API protocol. This allows vLLM to be used as a drop-in replacement for applications using OpenAI API. By default, it starts the server at http://localhost:8000.
VLLM_RPC_TIMEOUT=100000 vllm serve Qwen/Qwen2.5-72B-Instruct \
--trust-remote-code \
--dtype bfloat16 \
--max-model-len 32768 \
--tensor_parallel_size 4 \
--gpu-memory-utilization 0.95 \
--api-key token-abc123 \
--enable-auto-tool-choice \
--tool-call-parser hermes
Please check here if you wanna change Engine Arguments.
After you download the Qwen model, you need to change the default prompt in the tokenizer_config.json file (this line) by changing the You may call one or more functions to assist with the user query. to You should only call one tool at a time to assist with the user query..
The commands used to serve the open-source scientific and biomedical language models evaluated in this work are provided below:
Model: BioMistral-7B
Link: https://huggingface.co/BioMistral/BioMistral-7B
VLLM_RPC_TIMEOUT=10000 vllm serve BioMistral/BioMistral-7B \
--trust-remote-code \
--dtype bfloat16 \
--max-model-len 2048 \
--distributed-executor-backend mp \
--tensor_parallel_size 1 \
--gpu-memory-utilization 0.95 \
--api-key token-abc123 \
--max-num-seqs 1
Model: aaditya/Llama3-OpenBioLLM-8B
Link: https://huggingface.co/aaditya/Llama3-OpenBioLLM-8B
VLLM_RPC_TIMEOUT=10000 vllm serve aaditya/Llama3-OpenBioLLM-8B \
--trust-remote-code \
--dtype bfloat16 \
--max-model-len 8192 \
--distributed-executor-backend mp \
--tensor_parallel_size 1 \
--gpu-memory-utilization 0.95 \
--api-key token-abc123 \
--tokenizer meta-llama/Meta-Llama-3-8B-Instruct
Model: aaditya/Llama3-OpenBioLLM-70B
Link: https://huggingface.co/aaditya/Llama3-OpenBioLLM-70B
VLLM_RPC_TIMEOUT=10000 vllm serve aaditya/Llama3-OpenBioLLM-70B \
--trust-remote-code \
--dtype bfloat16 \
--max-model-len 8192 \
--distributed-executor-backend mp \
--tensor_parallel_size 4 \
--gpu-memory-utilization 0.95 \
--api-key token-abc123 \
--tokenizer meta-llama/Meta-Llama-3-70B-Instruct
Model: TsinghuaC3I/Llama-3.1-8B-UltraMedical
Link: https://huggingface.co/TsinghuaC3I/Llama-3.1-8B-UltraMedical
VLLM_RPC_TIMEOUT=10000 vllm serve TsinghuaC3I/Llama-3.1-8B-UltraMedical \
--trust-remote-code \
--dtype bfloat16 \
--max-model-len 8192 \
--distributed-executor-backend mp \
--tensor_parallel_size 1 \
--gpu-memory-utilization 0.95 \
--api-key token-abc123 \
--max-num-seqs 1
Model: TsinghuaC3I/Llama-3-70B-UltraMedical
Link: https://huggingface.co/TsinghuaC3I/Llama-3-70B-UltraMedical
VLLM_RPC_TIMEOUT=10000 vllm serve TsinghuaC3I/Llama-3-70B-UltraMedical \
--trust-remote-code \
--dtype bfloat16 \
--max-model-len 8192 \
--distributed-executor-backend mp \
--tensor_parallel_size 4 \
--gpu-memory-utilization 0.95 \
--api-key token-abc123
Model: PodGPT 70B
Link: https://huggingface.co/shuyuej/Llama-3.3-70B-Instruct-2048/tree/main/checkpoint-18640
VLLM_RPC_TIMEOUT=10000 vllm serve meta-llama/Llama-3.3-70B-Instruct \
--trust-remote-code \
--dtype bfloat16 \
--max-model-len 8192 \
--distributed-executor-backend mp \
--tensor_parallel_size 4 \
--gpu-memory-utilization 0.95 \
--api-key token-abc123 \
--enable-lora \
--lora-modules adapter=Llama-3.3-70B-Instruct-2048/checkpoint-18640
π§ Algorithm
Given a patientβs background and clinical question, the AI agent dynamically determines whether external evidence is required and autonomously invokes the appropriate tools.
When evidence retrieval is enabled, the system:
- Retrieves the top-K candidate documents from the medical evidence database.
- Reranks the candidates and selects the top-R most relevant documents.
- Processes the reranked documents incrementally in batches.
- Identifies and grounds relevant evidence from each batch.
- Stores useful evidence in a cache-and-prune memory bank while removing irrelevant information from the active context.
- Continues searching and grounding until sufficient evidence has been collected.
- Generates the final answer using the patient information, reasoning history, and grounded evidence retained in memory.
This iterative design allows the agent to integrate evidence beyond the modelβs effective context-window limit while ensuring that its final response is informed by the most relevant medical information.
πΌοΈ Structure of the code
At the root of the project, you will see:
.
βββ config.yml
βββ config_benchmark.yml
βββ retrieve.py
βββ rerank.py
βββ diagnosis.py
βββ run_retrieve.sh
βββ run_rerank.sh
βββ run_diagnosis.sh
βββ lib
β βββ framework.py
β βββ prompts.py
β βββ tools.py
βββ database
β βββ rag.py
βββ benchmarks
β βββ MedExpQA
β βββ MedQA
β βββ PubMedQA
β βββ USMLE
βββ evaluation-open-ended-QA
β βββ bert_score.py
β βββ GTE-embedding-Model.py
β βββ SFR-embedding-Model.py
βββ results
β βββ Ablation-study
β βββ Multiple-choice-QA
β βββ Open-ended-QA
β βββ Qwen3-models-for-rebuttal
βββ utils
βββ answer_extraction.py
βββ benchmark_utils.py
βββ utils.py
π Citation
If you find our work useful in your research, please consider citing it in your publications. We provide a BibTeX entry below.
@article{Jia2026agenticsystem,
title = {Agentic memory-augmented retrieval and evidence grounding for medical question-answering tasks},
author = {Shuyue Jia and Subhrangshu Bit and Varuna H. Jasodanand and Yi Liu and Vijaya B. Kolachalama},
journal = {International Journal of Medical Informatics},
volume = {212},
pages = {106339},
year = {2026},
issn = {1386-5056},
doi = {https://doi.org/10.1016/j.ijmedinf.2026.106339},
url = {https://www.sciencedirect.com/science/article/pii/S1386505626000791},
}
π§ Contact
Core Contributor and Maintainer:
Other Contributor and Maintainer:
If you have any questions, please drop us an email at brucejia@bu.edu.
π¨ Contributions
We always welcome contributions to help make our Agentic Medical RAG system better. If you would like to contribute, please submit a pull request.
π Acknowledgements
This repository is maintained by members of the Kolachalama Laboratory in Boston, MA.
- Downloads last month
- 25
